Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics

Peripartum cardiomyopathy is defined as left ventricular dilation and failure, first developing during the third trimester of pregnancy or in the first 6 months postpartum. In an effort to characterize this syndrome in a middle class population, 14 consecutive patients with peripartum cardiomyopathy underwent a detailed history and physical examination, right heart catheterization, M-mode and two-dimensional echocardiography, radionuclide ventriculography and right ventricular endomyocardial biopsy. These patients were then observed with sequential noninvasive studies to determine prognostic indicators. Eight (57%) of these 14 patients were primiparous and an equal number first presented with heart failure concomitant with or immediately before the onset of labor. When these women were compared with 55 patients with idiopathic dilated cardiomyopathy, only mean age at onset of symptoms (28.7 +/- 5.7 versus 48.2 +/- 13.6 years, p less than 0.001) and symptom duration (4.1 +/- 7.7 versus 19.0 +/- 18.4 months, p less than 0.001) differed between the groups. There was no difference in ventricular arrhythmia, left ventricular chamber size, ejection fraction or hemodynamics. Myocyte histologic findings were similar; however, myocarditis was identified in 29% of patients with peripartum cardiomyopathy and in only 9% of those with idiopathic dilated cardiomyopathy. In all patients with peripartum cardiomyopathy and myocarditis, the myocardial biopsy was performed within 1 week of onset of symptoms. Seven (50%) of the patients with peripartum cardiomyopathy had dramatic improvement within 6 weeks of follow-up, and 6 (43%) died.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. B. Chapa, H. B. Heiberger, L. Weinert, J. DeCara, R. M. Lang, and J. U. Hibbard Prognostic Value of Echocardiography in Peripartum Cardiomyopathy Obstet. Gynecol., June 1, 2005; 105(6): 1303 - 1308. [Abstract] [Full Text] [PDF]

				S A Thorne Pregnancy in heart disease Heart, April 1, 2004; 90(4): 450 - 456. [Full Text] [PDF]

				N. J. Mehta, R. N. Mehta, and I. A. Khan Peripartum Cardiomyopathy: Clinical and Therapeutic Aspects Angiology, November 1, 2001; 52(11): 759 - 762. [Abstract] [PDF]

				M T Kearney, J M Cotton, P J Richardson, and A M Shah Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management Postgrad. Med. J., January 1, 2001; 77(903): 4 - 10. [Abstract] [Full Text]

				G. D. Pearson, J.-C. Veille, S. Rahimtoola, J. Hsia, C. M. Oakley, J. D. Hosenpud, A. Ansari, and K. L. Baughman Peripartum Cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop Recommendations and Review JAMA, March 1, 2000; 283(9): 1183 - 1188. [Abstract] [Full Text] [PDF]

				J. U. Hibbard, M. Lindheimer, and R. M. Lang A MODIFIED DEFINITION FOR PERIPARTUM CARDIOMYOPATHY AND PROGNOSIS BASED ON ECHOCARDIOGRAPHY Obstet. Gynecol., August 1, 1999; 94(2): 311 - 316. [Abstract] [Full Text] [PDF]

				B. Bozkurt, F. S. Villaneuva, R. Holubkov, T. Tokarczyk, R. J. Alvarez Jr., G. A. MacGowan, S. Murali, W. D. Rosenblum, A. M. Feldman, and D. M. McNamara Intravenous immune globulin in the therapy of peripartum cardiomyopathy J. Am. Coll. Cardiol., July 1, 1999; 34(1): 177 - 180. [Abstract] [Full Text] [PDF]

				A. C. Borczuk, K. H. van Hoeven, and S. M. Factor Review and hypothesis: the eosinophil and peripartum heart disease (myocarditis and coronary artery dissection)--coincidence or pathogenetic significance? Cardiovasc Res, March 1, 1997; 33(3): 527 - 532. [Abstract] [PDF]

				M. R. Costanzo, S. Augustine, R. Bourge, M. Bristow, J. B. O'Connell, D. Driscoll, and E. Rose Selection and Treatment of Candidates for Heart Transplantation : A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association Circulation, December 15, 1995; 92(12): 3593 - 3612. [Abstract] [Full Text]

				N. K. Wenger, L. Speroff, and B. Packard Cardiovascular Health and Disease in Women N. Engl. J. Med., July 22, 1993; 329(4): 247 - 256. [Full Text]